GEN Exclusives

More »

GEN News Highlights

More »
Oct 19, 2006

U.S. Genomics and Lahey Clinic Will Study MicroRNAs Role in Predicting Urologic Cancers

  • U.S. Genomics and Lahey Clinic will study the role microRNAs play in the development of urologic cancers, according to a a discovery agreement between them. The company’s report that the objective of is to develop more accurate prognoses for bladder and prostate cancer patients.

    "This collaboration is intended to expedite the development of next-generation molecular diagnostic tests to determine the prognosis of several major urologic cancers," comments John Libertino, M.D., chairman of the department of urology, Lahey Clinic.

    The collaboration combines U.S. Genomics’ patented Trilogy® 2020 platform and Direct™ miRNA assay with Lahey Clinic's expertise in the analysis of tumor progression and experience in disease management.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?